Hideo Miki

Title: Hideo Miki: Innovator in Protein Biotechnology

Introduction

Hideo Miki is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of proteins for pharmaceutical applications. With a total of 3 patents to his name, Miki's work focuses on innovative processes for preparing proteins that have therapeutic potential.

Latest Patents

Miki's latest patents include a groundbreaking protein derived from human MP52. This protein has an amino acid sequence detailed in SEQ ID No.:1 of the Sequence Listing. The patent describes a homodimer protein that can be obtained through a series of steps, including constructing a plasmid, transforming it, and purifying the resulting monomer protein. The homodimer protein is particularly useful as a pharmaceutical composition for treating cartilage and bone diseases.

Career Highlights

Throughout his career, Hideo Miki has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Biopharm Gesellschaft zur Biotechnologischen Entwicklung Pharmaka GmbH and Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka GmbH. His work in these organizations has contributed to advancements in protein biotechnology.

Collaborations

Miki has collaborated with several professionals in his field, including Fusao Makishima and Hiroyuki Takamatsu. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in protein applications.

Conclusion

Hideo Miki's contributions to protein biotechnology demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of teamwork in achieving breakthroughs in the field.